Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Negative control of norepinephrine on the thyroid cyclic AMP system.

P Cochaux, J van Sande, J E Dumont

    Biochimica Et Biophysica Acta
    |September 13, 1982
    PubMed
    Summary

    Norepinephrine inhibits thyroid-stimulating hormone (TSH)-induced cyclic AMP (cAMP) in dog thyroid cells via alpha 2-adrenergic receptors. This effect directly impacts adenylate cyclase activity, offering insights into thyroid regulation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cancer heterogeneity is not compatible with one unique cancer cell metabolic map.

    Oncogene·2016
    Same author

    AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B.

    Nature communications·2016
    Same author

    Anoctamin-1/TMEM16A is the major apical iodide channel of the thyrocyte.

    American journal of physiology. Cell physiology·2014
    Same author

    Diphenyleneiodonium, an inhibitor of NOXes and DUOXes, is also an iodide-specific transporter.

    FEBS open bio·2013
    Same author

    Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and "swarm intelligence".

    Cancer metastasis reviews·2013
    Same author

    A gene expression signature distinguishes normal tissues of sporadic and radiation-induced papillary thyroid carcinomas.

    British journal of cancer·2012

    Area of Science:

    • Endocrinology
    • Molecular Biology
    • Pharmacology

    Background:

    • Thyroid-stimulating hormone (TSH) activates cyclic AMP (cAMP) production in thyroid cells.
    • Adrenergic agents can modulate thyroid function, but their specific mechanisms are not fully elucidated.

    Purpose of the Study:

    • To investigate the role of adrenergic agents in regulating the thyroid cyclic AMP system.
    • To determine the specific adrenergic receptor subtypes involved in the negative control of thyroid function.

    Main Methods:

    • Experiments using dog thyroid slices and isolated adenylate cyclase.
    • Measurement of cyclic AMP levels and enzyme activity.
    • Pharmacological characterization using specific receptor antagonists and agonists.

    Related Experiment Videos

    Main Results:

    • Norepinephrine inhibited TSH-induced cAMP increases and secretion in dog thyroid slices.
    • This inhibition was mediated by alpha 2-adrenergic receptors, as evidenced by blockade with yohimbine and lack of effect with prazosin or L-propranolol.
    • Norepinephrine also directly inhibited TSH-stimulated adenylate cyclase activity in a sodium-dependent manner, an effect blocked by phentolamine and yohimbine.

    Conclusions:

    • Adrenergic agents exert negative control on the dog thyroid cyclic AMP system.
    • This effect is primarily mediated by alpha 2-adrenergic receptors directly acting on adenylate cyclase.
    • Findings elucidate a novel regulatory pathway in thyroid hormone production.